1-1 of 1
Michael Chu, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

SD-101, a Novel Class C CpG-Oligodeoxynucleotide (ODN) Toll-like Receptor 9 (TLR9) Agonist, Given with Low Dose Radiation for Untreated Low Grade B-Cell Lymphoma: Interim Results of a Phase 1/2 Trial

Ronald Levy, MD, Patrick M. Reagan, MD, Jonathan W. Friedberg, MD, Nancy L Bartlett, MD, Leo I. Gordon, MD, Abraham Leung, MD, Joanna Peterkin, MD MS, Biao Xing, Robert Coffman, PhD, Robert Janssen, MD, Albert Candia, PhD, Michael Khodadoust, MD PhD, Matthew J. Frank, MD PhD, Steven R Long, MD, Debra K Czerwinski, Michael Chu, MD
Journal: Blood
Blood (2016) 128 (22): 2974.
https://doi.org/10.1182/blood.V128.22.2974.2974
Published: 2016